logo
JBA AI Earns FDA SaMD Recognition

JBA AI Earns FDA SaMD Recognition

Miami Herald09-06-2025
A New Era of Accessible Health Monitoring
GARDEN GROVE, CALIFORNIA / ACCESS Newswire / June 9, 2025 / JBA AI, the flagship health-tech division under AQ Pharmaceuticals, Inc. and JBA Brands, proudly announces several major global milestones in its mission to make preventive healthcare more accessible, intelligent, and affordable.
JBA AI has been officially recognized by the United States Food and Drug Administration (FDA) as a Software as a Medical Device (SaMD). In addition, the platform has now received Class B Medical Device approval from Vietnam's Ministry of Health. These achievements affirm the platform's safety, clinical effectiveness, and international credibility.
The JBA AI mobile application is already available globally for Android users and will soon be released on iOS. It enables contactless, non-invasive vital signs monitoring directly through smartphones or tablets. In just 60 seconds, the app delivers insights on over nine key health metrics. These include heart rate, heart rate variability, blood oxygen saturation, respiratory rate, stress index, and estimated glucose and blood pressure trends. This is achieved using AI-powered facial signal analysis through camera-based remote photoplethysmography technology.
Expanding its impact even further, JBA AI has partnered with one of Vietnam's largest financial institutions, which serves more than 30 millions members. Together, they are preparing to launch JBA AI nationwide, making preventive health monitoring more accessible through a trusted and widespread digital network.
"JBA AI is more than a health app - it's a certified medical device. Recognized by both the FDA and Vietnam's Ministry of Health," said Tracy Trang Nguyen, founder and CEO of JBA AI. "We're proud to deliver trusted, clinically guided tools for daily health monitoring worldwide."
Nguyen is a Vietnamese American engineer and wellness industry leader who developed JBA AI after surviving cancer. Her personal health journey inspired her to combine advanced artificial intelligence with affordable wellness solutions. Under her leadership, JBA AI complements other products within the JBA Brands portfolio, such as GlucoTrojan, Joint Revive Fucoidan, and Vegan Collagen, to form a fully integrated health ecosystem.
JBA AI is already gaining traction and is starting to expand into pharmacies, corporate wellness programs, public health campaigns, and family clinics across the United States, Vietnam, and other countries. The platform's franchise-ready model supports rapid local deployment while keeping costs low and impact high. It is designed to help people monitor their health in real-time, without the need for needles, wearable devices or clinic visits.
JBA AI is currently welcoming franchisees, affiliates, and institutional partners to help bring this technology to communities around the world. Whether at home or in partnership with healthcare providers, JBA AI is redefining preventive care through data-driven technology and a compassionate approach to well-being.
Contact Information
Catherine Marino Marketing Managercat@aqpharmaceuticals.com(+1) 714 903 1009
SOURCE: AQP One, Inc.
press release
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Implantica publishes Interim Report January - June 2025 (Q2)
Implantica publishes Interim Report January - June 2025 (Q2)

Yahoo

time4 minutes ago

  • Yahoo

Implantica publishes Interim Report January - June 2025 (Q2)

VADUZ, Liechtenstein, Aug. 14, 2025 /PRNewswire/ -- Transforming Clinical Excellence of RefluxStop® into Strategic Market Momentum Significant events in the second quarter of 2025 FDA PMA Submission Completed - Submitted third and final module of the U.S. FDA pre-market approval (PMA) application for RefluxStop®, including responses to questions on the second module; Feedback on module 3 expected in the near-term Produced and completed initial testing on new multi-cavity production tool for RefluxStop® to support launch of manufacturing in U.S. and manage ramp-up of U.S. production (pending FDA approval) Additional preparations for U.S. market launch (pending FDA approval) included U.S. payer and reimbursement activities, finalizing new production facility of RefluxStop® in U.S. and launching our RCT (randomized clinical trial), as a heavyweight cornerstone in building global leadership in acid reflux care Positive NICE Guidance in the UK - UK's National Institute for Health and Care Excellence (NICE) issued positive guidance for the use of RefluxStop® in NHS hospitals for patients with ineffective esophageal motility (IOM/IEM), potentially transforming treatment access for millions and influencing global policy Significant events after the end of the period Landmark 5-Year Clinical Study Results - Two peer-reviewed articles were published in Surgical Endoscopy on our pivotal study results; one publication confirmed outstanding long-term safety and effectiveness outcomes, and the second publication highlighted RefluxStop®'s excellent outcomes in food passageway-related sequelae, which is common in standard of care Randomized Clinical Trial (RCT) Launch - First RCT comparing RefluxStop® with Nissen fundoplication; patient recruitment underway accumulating patients across participating hospitals. While this trial preparation led to a 20% year-on-year revenue decline for Q2, the impact is expected to ease once study recruitment stabilizes Spanish Market Expansion - Three new hospitals added, totaling 19 centers offering RefluxStop® in Spain, with a healthcare sytem receptive for new and better patient care, which is a fantastic launch since 2023 First UK National Users Meeting - Convened 21 top anti-reflux experts to discuss real-world results, operating technique and the opportunities arising from NICE's positive recommendation Financial summary second quarter 2025 Net sales decreased 22% to TEUR 433 (554) due to the launch of the randomized clinical trial with surgeons accumulating patients for the trial. Adjusted gross margin amounted to 90% (91%). Operating loss (EBIT) decreased to TEUR 4,525 (5,869). Loss after tax decreased to TEUR 5,448 (6,431). Basic and diluted loss per Class A share amounted to EUR 0.08 (0.09). Cash and short-term investments as at the end of the period of MEUR 56.3. First six months Net sales increased 2% to TEUR 1,178 (1,150). Adjusted gross margin amounted to 94% (91%). Operating loss (EBIT) decreased to TEUR 8,698 (12,956). Loss after tax decreased to TEUR 8,212 (9,903). Basic and diluted loss per Class A share amounted to EUR 0.12 (0.14). Telephone conference Implantica will hold a teleconference on 14 August 2025 at 15:00 (CEST) with Peter Forsell (CEO), Andreas Öhrnberg (CFO), and Nicole Pehrsson (Chief Corporate Affairs Officer). Please see the dial-in details below to join the conference: Webcast If you wish to participate via webcast, please use the following link: Dial-in Dial-in numbers to the teleconference will be received by registering on the link below. After the registration, you will be provided phone numbers and a conference ID to access the conference. For further information, please contact:Nicole Pehrsson, Chief Corporate Affairs OfficerTelephone (CH): +41 (0)79 335 09 Implantica is listed on Nasdaq First North Premier Growth Market in Stockholm. The company's Certified Adviser is FNCA Sweden AB, info@ This information is information that Implantica AG is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2025-08-14 08:00 CEST. About Implantica: Implantica is a medtech group dedicated to bringing advanced technology into the body. Implantica's lead product, RefluxStop®, is a CE-marked implant for the prevention of gastroesophageal reflux that will potentially create a paradigm shift in anti-reflux treatment as supported by successful clinical trial results. Implantica also focuses on eHealth inside the body and has developed a broad, patent protected, product pipeline based partly on two platform technologies: an eHealth platform designed to monitor a broad range of health parameters, control treatment from inside the body and communicate to the caregiver on distance and a wireless energising platform designed to power remote controlled implants wirelessly through intact skin. Implantica is listed on Nasdaq First North Premier Growth Market (ticker: IMP A SDB). Visit for further information. This information was brought to you by Cision The following files are available for download: Implantica Q2 2025_ENG Implantica publishes Interim Report Jan - Jun 2025 Q2 View original content:

Soligenix receives FDA orphan designation for dusquetide
Soligenix receives FDA orphan designation for dusquetide

Business Insider

time3 hours ago

  • Business Insider

Soligenix receives FDA orphan designation for dusquetide

Soligenix's (SNGX) dusquetide, a treatment of Behcet's disease , received FDA orphan designation, according to a post to the agency's website. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Doctors And Patients Are Sharing The 'Mild' Symptoms That Actually Could Be A Sign Of Something Very, Very Major
Doctors And Patients Are Sharing The 'Mild' Symptoms That Actually Could Be A Sign Of Something Very, Very Major

Yahoo

time3 hours ago

  • Yahoo

Doctors And Patients Are Sharing The 'Mild' Symptoms That Actually Could Be A Sign Of Something Very, Very Major

Recently, I saw a post on the popular Ask Reddit page from user BenneIdli asking, "Doctors and former patients: what is a mild symptom that you should take a second opinion on just to rule out something major?" While this isn't medical advice, I definitely think it's worth it to be aware of any potential mild symptoms that can morph into something far more dramatic; so, I decided to share. Here are some of the most useful and interesting answers: hands and feet. My mum had a tumour in her pancreas, and this was the symptom her GP (a fantastic GP) took as a sign to get further testing. I don't think she would be here now if it weren't for him taking it seriously." "The itchy hands and feet were caused by a buildup of bilirubin in her bile ducts, caused by the tumor in her pancreas. She ended up having a Whipple procedure done, and they found the cancer early, no further treatment, and it's been 11 years, full recovery." —u/crankyT27 "Pancreatic cancer is the absolute worst. Glad they found it early and that your mom made a full recovery! 🫶" —u/noracordelia 2."If you (or your mom) have already been through menopause but your period 'comes back' even just once, INSIST on testing. Post-menopausal uterine bleeding is uterine cancer until proven otherwise." —u/WeAreNotNowThatWhich "Yup. My mom had gone through menopause 10 years prior, when suddenly she started bleeding again. The assistant told her this wasn't anything to worry about and told her to wait. A month later, she finally got an appointment and was immediately sent to the hospital. Full-blown ovarian cancer. Her uterus was basically filled to the brim with cancer. We got so lucky. It hadn't spread, and they were able to take out everything without any repercussions (besides a horrible-looking scar). Fuck that assistant." —u/Blackneomil Related: 3."My father recently died of acute myeloid leukemia. Keep in mind, he vehemently refused checkups or doctors' visits for any reason. Seemingly innocuous symptoms clustered together can be a sign of a much bigger issue, as I have learned. From my memory, he slept way too much (fatigue)." "He had frequent colds that he kept taking over-the-counter medicine for. He had weakness that we didn't catch. Close to the end, he had stomach issues for many days (I discovered this by chance). The sudden, alarming weight loss was the last straw. I forced him to the hospital and he was dead in less than a week. Separately, all those issues are usually nothing serious, but in this instance, they were a huge warning sign that he chose to ignore. —u/Here_for_tea85 4."Sudden weight loss." —u/lazuli_s 5."Doctors told my mom she 'just had arthritis' when she kept complaining of back pain. She had a large tumour on her spine and died less than two months from it finally being found. Always get multiple opinions." —u/LibbyBaby2000 6."My OB/GYN once noted that my thyroid seemed a little big, but shrugged it off once my blood tests came back normal. It was cancer." Pop TV / CBC Television "That was discovered later on. Thankfully, it was a slow-growing and easily treatable type, but still a case for following up on anything that seems even slightly odd." —u/MadamNerd 7."Being more tired than usual. People tend to think they're just getting older, maybe overworked, maybe stressed, etc., but it could be an easily fixed thing like a vitamin deficiency, or it could be something serious but treatable like hypothyroid, or any number of things that are urgent and need attention. Sleep apnea, heart disease, etc." —u/NotMyNameActually Related: 8."Increasingly heavy periods." —u/TheYankunian "Increasingly lighter periods, too." —u/hummusy 9."Night pain in the hips or back (or really any bone, but those are big ones) and more specifically, pain that wakes you up at night, especially in kids. Nothing will get you an MRI faster in the pediatric ortho world." —u/ohKilo13 10."Thought I had random heartburn that only showed up when I walked up stairs. No chest pain, just a tight belt feeling and a little jaw ache. I went to urgent care, and troponins were positive. It was a heart attack. If 'indigestion' shows up with exertion or comes with jaw or arm weirdness, get checked fast." NBC —u/Reasonable_Dance_469 11."A wart that just keeps coming back after treatment." "Eventually they took a biopsy, and suddenly it went from 'oh, this is annoying' to 'I might die in three months' for my father. It was Merkle Cell Carcinoma and luckily only took part of a limb rather than his whole life." —u/UncomfortablyHere Related: 12."Bleeding after sex. Pain during sex. Ladies, make sure you have your smear tests. Please." —u/GingerbreadMary "Agree. Had those symptoms and ended up having stage 3 cervical cancer at 22 years old." —u/Ambitious_Phrase3695 13."Blood in stool may indicate intestinal bleeding that can lead to death within hours." —u/PassengerNo2022 14."When your 'just a headache' starts waking you up at night, get that checked." —u/Suspicious_Level3366 "Pretty much any pain that is significant enough to wake you up from a sound sleep is something to get checked out, not just headaches." —u/twistedscorp87 15."Sharp pain in sternum shortly after drinking even a small amount of alcohol." "I thought it was just kinda weird, was dismissed by a GP twice as probably just a strain or injury, and finally a third GP sent me for an ultrasound, which suddenly turned into a battery of more serious out it was an obscure but known symptom of Hodgkin's Lymphoma. Was stage 4 by that point, but chemo did its thing and here I am 16 years later." —u/bazpoint 16."Pulsatile tinnitus — hearing a dull thudding or wooshing sound in your ear that matches your heartbeat. It's normal to have your heart pounding in your ears immediately after strenuous exertion, but if you can hear your heartbeat in one or both ears at rest, that is concerning." "What you're hearing may be a bruit (pronounced 'bruey'), a sound caused by turbulent bloodflow. Something may be compressing one of your arteries, such as a swollen lymph node or a tumor. Or something has changed the shape of a blood vessel. Whatever the cause, it warrants immediate investigation. I had a bulbus dissection of my left internal carotid artery, and pulsatile tinnitus was the only symptom." —u/MrBarraclough 17."Tooth infection can lead to heart attack, who would have known?! (I'm not a doctor, but it happened to a friend and he nearly died.)" —u/Cultural-Chart3023 Related: 18."Sudden loss of balance. It was my dad's only symptom of a stroke. Luckily, he recovered, but he needed a cardiac catheterization and was found to have heart failure as well." —u/StrongArgument 19."Skin bump that bleeds. Yeah, skin cancer does that." —u/que_he_hecho finally: "Back pain. My dad kept going to his doctor about his back hurting, and was told to just take Robaxacet. He turned jaundiced, went to the emergency room, and stayed for three days getting out to be cancer. Less than six months later, he was dead." —u/Quirky_March_626 If you made it to the end of this article, congratulations! I myself am sitting here horrified, but I'm glad I read these — it's so important to know the red flag symptoms to look out for. If you have any thoughts, tell me about 'em in the comments — even better if you have a story of your own to share. Or, if you have a story to share but prefer to remain anonymous, you can check out this anonymous form! Also in Goodful: Also in Goodful: Also in Goodful: Solve the daily Crossword

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store